Friday 4 April 2003
Organizer R. Corrocher (Verona, Italy)

Hyperhomocysteinemia: pathophysiology and clinical implications

Session I
Chairs H. Blom (Nijmegen, The Netherlands) & R. Corrocher (Verona, Italy) Abstract No.
09.40 – 10.05 One-carbon metabolism and DNA methylation
S. Friso (Boston, USA / Verona, Italy)
10.05 – 10.30 MTHFR genotype, homocysteine, and risk of cardiovascular disease
D. Girelli (Verona, Italy)
10.30 – 10.55 Homocysteine as a risk of deep vein thrombosis
M. Cattaneo (Milano, Italy)
11.00 – 11.15 coffee break
11.15 – 11.40 Homocysteine and Alzheimer disease
G. Di Minno (Napoli, Italy)
11.40 – 12.05 B-vitamins, hyperhomocysteinemia and risk of neural tube defects
H. Blom (Nijmegen, The Netherlands)
12.05 – 1230 Discussion
12.30-12.40 Plasma homocysteine (tHcy) and kidney in diabetes mellitus
O. Giampietro, D. Calvi, G. Forotti, E. Boldrini, L. Moretti, and E. Matteucci (Pisa, Italy)
210
12.40 – 12.50 Determinants of total homocysteine plasma levels in type 2 diabetes
G.T. Russo, E. Alessi, A. Di Benedetto, G. Raimondo, and D. Cucinotta (Messina, Italy)
211
12.50 – 13.00 Prevalence of hyperhomocyst(e)inemia in patients with angiographically-assessed coronary artery disease and its associaton with peripheral vascular disease and chronic renal failure in the “GENICA” study
M. Cesari, M. Zanchetta, C. Ferrante, L. Pedon, P. Maiolino, A.C. Pessina, and G.P. Rossi (Padova, Italy)
212
13:00 End of workshop

Posters

212A
Homocysteinemia and ischaemic risk
C. Belizna, M.A. Pistorius, and B. Planchon (Nantes, France)

212B
Plasma homocysteine and vitamin B6 levels in relation to clinical evidence of atherosclerosis in type-2 diabetic patients
M. Cigolini, M. Galiotto, G. Faccini,V. Miconi, S. Lombardi, and R. Corrocher (Arzignano/Verona, Italy)